Resistance and Co-Resistance of Metallo-Beta-Lactamase Genes in Diarrheal and Urinary-Tract Pathogens in Bangladesh.
Bangladesh
antimicrobial resistance
antimicrobial stewardship programs
blaNDM-1
blaVIM
co-resistance
diarrhea
metallo-beta-lactamase
urinary tract infections
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
05 Aug 2024
05 Aug 2024
Historique:
received:
27
06
2024
revised:
24
07
2024
accepted:
03
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Carbapenems are the antibiotics of choice for treating multidrug-resistant bacterial infections. Metallo-β-lactamases (MBLs) are carbapenemases capable of hydrolyzing nearly all therapeutically available beta-lactam antibiotics. Consequently, this research assessed the distribution of two MBL genes and three β-lactamases and their associated phenotypic resistance in diarrheal and urinary-tract infections (UTIs) to guide future policies. Samples were collected through a cross-sectional study, and β-lactamase genes were detected via PCR. A total of 228 diarrheal bacteria were isolated from 240 samples. The most predominant pathogens were
Identifiants
pubmed: 39203431
pii: microorganisms12081589
doi: 10.3390/microorganisms12081589
pmc: PMC11356267
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Bangladesh Medical Research Council (BMRC)
ID : BMRC/Research Grant/2021-2022/75(1-23)
Références
Nat Commun. 2024 Jan 12;15(1):494
pubmed: 38216585
Clin Infect Dis. 2017 Feb 1;64(3):257-264
pubmed: 28013264
Am J Med. 2002 Jul 8;113 Suppl 1A:14S-19S
pubmed: 12113867
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Int J Clin Pract. 2022 Oct 13;2022:3639943
pubmed: 36311485
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
BMC Res Notes. 2013 Nov 25;6:487
pubmed: 24274894
Open Forum Infect Dis. 2019 Jul 28;6(8):ofz344
pubmed: 31660388
Clin Microbiol Rev. 2005 Apr;18(2):306-25
pubmed: 15831827
J Pharm Policy Pract. 2021 Nov 16;14(Suppl 1):85
pubmed: 34784981
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32312775
Lancet Infect Dis. 2020 Jan;20(1):37-59
pubmed: 31678029
APMIS. 2007 Dec;115(12):1400-8
pubmed: 18184411
PLoS One. 2021 Sep 8;16(9):e0256308
pubmed: 34495985
IJID Reg. 2023 Feb 10;7:11-17
pubmed: 36941825
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Antimicrob Resist Infect Control. 2015 Apr 17;4:12
pubmed: 25908966
Lancet. 2016 Oct 8;388(10053):1448-1449
pubmed: 27733278
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
Antibiotics (Basel). 2022 Feb 14;11(2):
pubmed: 35203851
Curr Opin Pharmacol. 2007 Oct;7(5):459-69
pubmed: 17875405
Clin Microbiol Infect. 2010 Feb;16(2):112-22
pubmed: 20085605
Int J Infect Dis. 2019 Mar;80:54-61
pubmed: 30634043
JAC Antimicrob Resist. 2019 Nov 12;1(3):dlz072
pubmed: 34222945
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Int J Infect Dis. 2020 Jul;96:621-629
pubmed: 32505875
Clin Microbiol Infect. 2022 Sep;28(9):1193-1202
pubmed: 35339675
Indian J Pediatr. 2011 Feb;78(2):165-70
pubmed: 20924718
Nat Commun. 2023 Aug 8;14(1):4764
pubmed: 37553339
J Nepal Health Res Counc. 2012 Sep;10(22):208-13
pubmed: 23281453
Clin Infect Dis. 2018 Mar 19;66(7):1061-1067
pubmed: 29099915
Expert Rev Anti Infect Ther. 2016;14(1):95-108
pubmed: 26535959
Ther Adv Urol. 2019 May 02;11:1756287219832172
pubmed: 31105774
PLoS One. 2020 Jan 27;15(1):e0227947
pubmed: 31986167
Antimicrob Resist Infect Control. 2019 Feb 12;8:35
pubmed: 30805182
Lancet Infect Dis. 2019 Dec;19(12):1278-1280
pubmed: 31782385
BMC Infect Dis. 2018 Feb 1;18(1):63
pubmed: 29390982
Antibiotics (Basel). 2022 Mar 12;11(3):
pubmed: 35326841
Lancet Infect Dis. 2020 Jun;20(6):731-741
pubmed: 32151332
Clin Infect Dis. 2018 Apr 3;66(8):1290-1297
pubmed: 29165604
Iran J Basic Med Sci. 2021 Feb;24(2):136-142
pubmed: 33953851
Ther Adv Infect Dis. 2018 Jan;5(1):29-43
pubmed: 29344358
Diagn Microbiol Infect Dis. 2011 May;70(1):119-23
pubmed: 21398074
Glob Health Sci Pract. 2021 Sep 30;9(3):532-547
pubmed: 34593580
Med Sci (Basel). 2017 Dec 21;6(1):
pubmed: 29267233
Antimicrob Agents Chemother. 2011 Nov;55(11):4943-60
pubmed: 21859938
Iran J Microbiol. 2021 Jun;13(3):303-311
pubmed: 34540168
Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S
pubmed: 12113866
Ann N Y Acad Sci. 2013 Jan;1277:91-104
pubmed: 23163348
Iran J Microbiol. 2015 Apr;7(2):72-8
pubmed: 26622967
J Hosp Infect. 2024 Feb;144:56-65
pubmed: 38070709
Microb Genom. 2018 Jul;4(7):
pubmed: 30035710
Clin Microbiol Infect. 2022 Dec;28(12):1533-1535
pubmed: 36007869
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
Nat Rev Microbiol. 2019 Jan;17(1):3
pubmed: 30467331
Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(10):1025-1055
pubmed: 37740561
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2053-2068
pubmed: 34169446
Infect Dis Ther. 2021 Mar;10(1):75-92
pubmed: 33492641
Crit Care. 2010;14(3):R113
pubmed: 20546564
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30858212
J Antimicrob Chemother. 1995 Jan;35(1):1-5
pubmed: 7768757
BMC Health Serv Res. 2022 Oct 7;22(1):1239
pubmed: 36207710
Pak J Med Sci. 2020 Sep-Oct;36(6):1297-1302
pubmed: 32968397
Curr Opin Pharmacol. 2011 Oct;11(5):477-85
pubmed: 21840259
mSystems. 2020 Jun 23;5(3):
pubmed: 32576652
Gut Pathog. 2017 Apr 20;9:19
pubmed: 28439298
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Drug Resist Updat. 2015 May;20:29-38
pubmed: 26004211
J Glob Antimicrob Resist. 2020 Sep;22:317-324
pubmed: 32247077
Ci Ji Yi Xue Za Zhi. 2016 Jul-Sep;28(3):94-98
pubmed: 28757733
Infect Drug Resist. 2020 Aug 18;13:2863-2875
pubmed: 32903880
Sci Rep. 2020 Oct 14;10(1):17292
pubmed: 33057111
Med Clin North Am. 2018 Sep;102(5):805-818
pubmed: 30126572
J Clin Microbiol. 2010 Jul;48(7):2402-6
pubmed: 20484603
Clin Microbiol Infect. 2017 Nov;23(11):812-818
pubmed: 28712667
J Clin Pharm Ther. 2018 Feb;43(1):59-64
pubmed: 28833324
Infect Drug Resist. 2019 Dec 20;12:3903-3910
pubmed: 31908502
Antibiotics (Basel). 2019 May 28;8(2):
pubmed: 31141983